Financials
Financial year 2024
APOTHEEK DEMEER from Leuven, company number BE0446367670, closed financial year 2024 with a result of € 43,595 after tax. For that financial year APOTHEEK DEMEER recorded a gross margin of € 184,224 and equity of € 367,094. Compared with financial year 2023, the result moved from € 65,003 to € 43,595. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 12, 2025.
€ 367,094
▲ 1% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 43,595
▼ 33% vs 2023
Profit after tax over the fiscal year.
€ 43,596
▼ 50% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 40,000 paid out
92 % of the profit went to the shareholders, mostly to Ansophar BV (100 % of the shares). That is where the money ends up.
People and assets in 2024
1.2
▼ 0.1 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 73,731
▼ 41% vs 2023
€ 61,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,894
▼ 30% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 212,621
▼ 10% vs 2023
€ 27,299 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 48,897
▼ 64% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 9,924
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 182,521 | € 289,116 | € 184,224 | ▼ 36% |
| Profit after taxes | € 56,406 | € 65,003 | € 43,595 | ▼ 33% |
| Equity | € 323,497 | € 363,500 | € 367,094 | ▲ 1% |
| Total debts | € 429,999 | € 413,407 | € 315,199 | ▼ 24% |
| Cash | € 67,497 | € 86,886 | € 43,596 | ▼ 50% |
| Land & buildings | € 350,867 | € 300,547 | € 248,019 | ▼ 17% |
| Retained profit | € 106,411 | € 146,414 | € 150,009 | ▲ 2% |
| Dividend | € 0 | € 25,000 | € 40,000 | ▲ 60% |
| Bank debt | € 330,160 | € 237,330 | € 212,621 | ▼ 10% |
| Balance sheet total | € 753,496 | € 776,906 | € 682,293 | ▼ 12% |
| Employees (FTE) | 1.1 | 1.3 | 1.2 | ▼ 0.1 |
Key figures of APOTHEEK DEMEER, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to APOTHEEK DEMEER?
What happened at APOTHEEK DEMEER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 43,595 (▼ 33% vs 2023). filed late Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 56,406 profit in 2022 to € 43,595 profit in 2024.
Paid € 2,618 in corporate taxes since 2022.
Best year ever: 2023, with € 65,003 profit.
On average € 153,500 of value added per employee in 2024.
A new publication or filing at APOTHEEK DEMEER? We notify you, reason included.
Follow APOTHEEK DEMEERDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind APOTHEEK DEMEER are Ansophar BV and Alaerts Sven. The shares are held by Ansophar BV (100%).
Directors
According to the 2024 annual accounts
Managing director · represented by Ann-Sophie Demeer
Alaerts Sven
Director
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Naamsesteenweg 224
3001 Leuven
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
DNS
Cloudflare DNS
Domain
Domain
apotheekdemeer.be
Registered
2017-10-12
Website info
Features
Security
Network
Details
- Company number
- 0446.367.670
- VAT number
- BE 0446.367.670
- Registered office
- Naamsesteenweg 224, 3001 Leuven
- Names & denominations
- APOTHEEK DEMEER
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 1992
- Peppol
- Active · Active since 4 Dec 2025
- Contact
- apotheekdemeer.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers